Owner Corixa Corporation Gaiger, A.

Inventors Vedvick, Thomas S; Smithgall, Molly; Mossman, Sally; Spies, A. Gregory; McNeill, Patricia D.; Boydston, Jeremy; Moulton, Gus; Gaiger, Alexander; Evans, Lawrence; Sleath, Paul R

Agent Davies Collison Cave

Pub. Number AU-B-2001296608

PCT Pub. Number WO02/28414

Priority 09785019 15.02.01 US; 09938864 24.08.01 US; 09684361 06.10.00 US; 09685830 09.10.00 US

Filing date 3 October 2001

Wipo publication date 15 April 2002

Acceptance publication date 24 May 2007

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids